JP2017529322A5 - - Google Patents

Download PDF

Info

Publication number
JP2017529322A5
JP2017529322A5 JP2017505548A JP2017505548A JP2017529322A5 JP 2017529322 A5 JP2017529322 A5 JP 2017529322A5 JP 2017505548 A JP2017505548 A JP 2017505548A JP 2017505548 A JP2017505548 A JP 2017505548A JP 2017529322 A5 JP2017529322 A5 JP 2017529322A5
Authority
JP
Japan
Prior art keywords
moiety
polymer
integer
substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017505548A
Other languages
English (en)
Japanese (ja)
Other versions
JP6704900B2 (ja
JP2017529322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/043297 external-priority patent/WO2016019340A1/en
Publication of JP2017529322A publication Critical patent/JP2017529322A/ja
Publication of JP2017529322A5 publication Critical patent/JP2017529322A5/ja
Application granted granted Critical
Publication of JP6704900B2 publication Critical patent/JP6704900B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017505548A 2014-07-31 2015-07-31 ポリオキサゾリン抗体薬物複合体 Active JP6704900B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462031382P 2014-07-31 2014-07-31
US62/031,382 2014-07-31
PCT/US2015/043297 WO2016019340A1 (en) 2014-07-31 2015-07-31 Polyoxazoline antibody drug conjugates

Publications (3)

Publication Number Publication Date
JP2017529322A JP2017529322A (ja) 2017-10-05
JP2017529322A5 true JP2017529322A5 (https=) 2018-08-30
JP6704900B2 JP6704900B2 (ja) 2020-06-03

Family

ID=55178936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017505548A Active JP6704900B2 (ja) 2014-07-31 2015-07-31 ポリオキサゾリン抗体薬物複合体

Country Status (7)

Country Link
US (2) US10071168B2 (https=)
EP (1) EP3180388A4 (https=)
JP (1) JP6704900B2 (https=)
KR (1) KR20170046141A (https=)
CN (1) CN106715533B (https=)
CA (1) CA2956709A1 (https=)
WO (1) WO2016019340A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110366430A (zh) * 2016-12-23 2019-10-22 联邦科学和工业研究组织 用于靶向递送试剂的生物相容且亲水的聚合物缀合物
US20220411463A1 (en) * 2019-03-18 2022-12-29 Khashayar Karimian Mate and separate: a convenient and general method for the separation and purification of target molecules from biological media by phase transition of pegylated recognition agents.
WO2020247151A1 (en) * 2019-06-05 2020-12-10 Boston Scientific Scimed, Inc. Click chemistry capturable platinum-based antineoplastic agents
MX2024002726A (es) 2021-09-03 2024-03-20 CureVac SE Nuevas nanoparticulas lipidicas para la administracion de acidos nucleicos.
WO2023031392A2 (en) 2021-09-03 2023-03-09 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine
WO2023073228A1 (en) 2021-10-29 2023-05-04 CureVac SE Improved circular rna for expressing therapeutic proteins
EP4430076A2 (en) * 2021-11-08 2024-09-18 Life Technologies AS Polymer-interaction molecule conjugates and methods of use
US20250099614A1 (en) 2022-01-28 2025-03-27 CureVac SE Nucleic acid encoded transcription factor inhibitors
WO2023212621A1 (en) * 2022-04-26 2023-11-02 University Of Virginia Patentfoundation Development of nano-encapsulated fatty-acyl conjugated colchicine
KR20250153298A (ko) 2023-03-08 2025-10-24 큐어백 에스이 핵산 전달을 위한 신규의 지질 나노입자 제형
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871720B2 (en) * 2005-07-07 2014-10-28 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
US20140011964A1 (en) 2007-02-28 2014-01-09 Serina Therapeutics, Inc. Activated Polyoxazolines and Conjugates and Compositions Comprising the Same
KR101508621B1 (ko) * 2007-02-28 2015-04-07 세리나 쎄라퓨틱스, 인코포레이티드 활성화된 폴리옥사졸린 및 이를 포함하는 조성물
US8110651B2 (en) 2008-01-11 2012-02-07 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
US8101706B2 (en) 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
DK2528625T3 (da) * 2010-04-15 2013-10-14 Spirogen Sarl Pyrrolobenzodiazepiner og konjugater deraf
WO2013020005A2 (en) 2011-08-03 2013-02-07 Anp Technologies, Inc. Oxazoline polymer compositions and use thereof
US8383093B1 (en) 2011-11-01 2013-02-26 Serina Therapeutics, Inc. Subcutaneous delivery of poly(oxazoline) conjugates

Similar Documents

Publication Publication Date Title
JP2017529322A5 (https=)
JP2016153410A5 (https=)
JP2006502741A5 (https=)
JP2023098946A5 (https=)
JP2012512898A5 (https=)
JP2010521485A5 (https=)
RU2020123953A (ru) Ингибирующие bcl-xl соединения, обладающие низкой клеточной проницаемостью, и конъюгаты антитело-лекарственное средство, включающие их
JP2014231516A5 (https=)
RU2008110495A (ru) Конъюгаты лиганда с несколькими лекарственными средствами
RU2011129764A (ru) Лекарственные средства, связанные с дипептидами
JP2020519643A5 (https=)
RU2008149932A (ru) Высокомолекулярный конъюгат подофиллотоксинов
JP2008528658A5 (https=)
JP2009504784A5 (https=)
JP2013531659A5 (https=)
JP2007502293A5 (https=)
RU2006105101A (ru) Арилокси и арилалкиленокси замещенные имидазохинолины
RU2009105670A (ru) Высокомолекулярный конъюгат комбретастатинов
JP2014506892A5 (https=)
JP2006523437A5 (https=)
RU2017117634A (ru) Способы получения конъюгатов
JP2006505634A5 (https=)
JP2014520120A5 (https=)
JP2015520184A5 (https=)
JP2004506645A5 (https=)